Clinical Trial Update: Neoadjuvant Radiation Therapy and Capecitabine in Treating Patients With Stage III or Stage IV Colorectal Adenocarcinoma [Phase 2]

View source ↗

Summary

Describes a Phase 2 clinical trial evaluating neoadjuvant radiation therapy with capecitabine for stage III or stage IV colorectal adenocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Xeloda (capecitabine)

Snippet

Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group | Conditions: Colorectal Cancer | Phase 2 | Status: UNKNOWN